Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pneumonia

• High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia
• Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
• High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB
• A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
• Acyclovir in Mechanically Ventilated Patients With Pneumonia and HSV-1 in BAL
• Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy
• Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function
• Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function
• A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex
• The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia
• Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
• P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
• Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
• The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Induced Pneumonia.
• Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
• Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
• AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
• Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
• Effect of High Dose Intravenous Vitamin C in Severe Pneumonia
• Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
• Evaluation of the Efficacy and Safety of Nano-S1
• Traditional Chinese Medicine or Low-dose Dexamethasone in COVID-19 Pneumonia
• Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
• Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
• Macrophage Regulation of Ozone-Induced Lung Inflammation
• Research on the Treatment of Severe Community-acquired Pneumonia in Children
• Oxygen Atomizing Inhalation of EGCG in the Treatment COVID-19 Pneumonia in Cancer Patients
• The Effect of Zoledronate on the Prevention of Pneumonia in Hip Fracture Patients
• Supportive Treatment and Antibiotics for Mild Pediatric Pneumonia
• Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
• The Effect of Huashibaidu Granule on Community-acquired Pneumonia in Children
• Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
• Efficacy and Safety of Jaktinib in Patients With Severe Novel Noronavirus Pneumonia
• Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
• A Study of Jacktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia
• An Efficacy and Safety Study of Jacktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia
• A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558
• PK of BV100 in Patients VABP Suspected or Confirmed to be Due to CRAB
• UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients
• Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumoia
• Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
• A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101
• An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
• Multicenter, Double-blind, Randomized, Placebo-controlled Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 Pneumonia
• The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days
• Efficacy and Safety of Trimodulin (BT588) in Subjects With Moderate or Severe COVID-19
• Zinc Intervention in Elderly for Prevention of Pneumonia
• Effect of Lactoferrin in Pneumonia Treatment
• PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)
• Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
• Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model
• Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia
• FAPI PET for Lung Fibrosis
• A Controlled Human Pneumococcal Infection Model (PIM) Study
• HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
• Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients
• Individualizing Corticosteroid Use in Pneumonia
• A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
• Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
• Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
• Nebulised Heparin in Patients With COVID-19 Pneumonia
• Reparixin as add-on Therapy to Standard of Care to Limit Disease Progression in Adult Patients With COVID-19.
• Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia
• Nebulised BromAc in Healthy Volunteers
• Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
• Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults
• To Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Recarbrio in Adults With HABP /VABP
• A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia
• SP16 as a Therapeutic for SARS-CoV-2 Induced ARDS
• Oral Nemonoxacin in Treating Elderly Patients With CAP
• Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care
• Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.
• BL Infusion Trial: Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia
• Early Antibiotics After Aspiration in ICU Patients
• Cromolyn Sodium for Treatment of COVID-19 Pneumonia
• Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia
• Efficacy of PJS-539 for Adult Patients With COVID-19.
• Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab
• Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)
• Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip
• Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19
• Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection
• Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus
• Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
• MANS-NRIZ Trial for COVID-19 Treatment : Extension Study
• Yinhu Qingwen Granule in the Treatment of Viral Pneumonia
• Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT
• Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
• The Use of Tadalafil in Confirmed COVID-19 Pneumonia.
• IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.
• Safety and Effectiveness of an Immunobiological Drug in CoViD-19
• Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.
• Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation
• Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia
• Ivermectina Colombia (IVERCOL)
• The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients
• Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
• A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia
• Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.
• Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19
• Metoclopramide vs Placebo for Prevention of Pneumonia in Acute Stroke
• Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314
• Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia
• Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
• Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
• DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia
• Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19
• Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial
• Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19
• ANTIcoagulation in Severe COVID-19 Patients
• The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
• Reparixin in COVID-19 Pneumonia - Efficacy and Safety
• Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study
• Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
• Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
• Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer
• Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)
• Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management
• Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia
• Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia
• Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)
• Antiviral Drugs on the Treatment of SARS-CoV-2
• Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19
• Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
• Nebulized Heparin for the Treatment of COVID-19
• Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia
• A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia
• Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia
• TCM Syndrome Differentiation Treatment on Discharged Elderly Patients With CAP
• 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
• Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia
• Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis
• Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
• Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
• Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients
• Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)
• A Study of Auxora in Patients With Critical COVID-19 Pneumonia
• Corticosteroids in Community Acquired Pneumonia
• Effects of Fuzheng Huayu Tablets on COVID-19
• Anakinra in the Management of COVID-19 Infection
• Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)
• Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients
• Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
• A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
• Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.
• FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia
• A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
• Treat COVID-19 Patients With Regadenoson
• Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia
• GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
• D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia
• Inflammatory Signal Inhibitors for COVID-19 (MATIS)
• A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure
• Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19
• GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia
• Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
• Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients
• Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
• Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia
• Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia
• Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19
• Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia
• Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
• Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia
• Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia
• Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients
• Toclizumam Versus Dexamethasone in Severe Covid-19 Cases
• Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
• Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection
• Effect of Chlorhexidine-Induced Oral Care on Ventilator-Related Some Respiratory System Complications
• Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
• To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
• Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
• Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.
• Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae
• Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
• Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia
• Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial
• Eosinophil-guided Reduction of Inhaled Corticosteroids
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
• Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement
• COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients
• Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia
• Low Versus High Corticosteroid Use in Ventilator Associated Pneumonia
• Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
• Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs
• Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia
• A Study of Combination Therapies to Treat COVID-19 Infection
• Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
• Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia
• Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia
• Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)
• Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation
• Prasugrel in Severe COVID-19 Pneumonia
• Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
• Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19
• Universal Anti-Viral Vaccine for Healthy Elderly Adults
• A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
• Glucocorticoids in COVID-19 (CORTIVID)
• Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
• Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
• Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS
• Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia
• A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）
• MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)
• Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19
• The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia
• Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19
• Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia
• PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS
• A Study of Opaganib in Coronavirus Disease 2019 Pneumonia
• Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19
• Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy
• Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury
• A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
• High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy
• Hydroxychloroquine, Azithromycin in the Treatment of Covid-19
• 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia
• Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
• TD-0903 for ALI Associated With COVID-19
• This Study Aim is to Compare the Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis as it Was Found That Not All Patients Get Satisfying Therapeutic Effect After Taking Corticosteroids.
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
• Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial
• Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
• Silymarin in COVID-19 Pneumonia
• Ultra Low Doses of Therapy With Radiation Applicated to COVID-19
• Baricitinib Compared to Standard Therapy in Patients With COVID-19
• LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia
• TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia
• A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia
• Study of Efficacy and Safety of MAS825 in Patients With COVID-19
• Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial
• Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia
• Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia
• Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
• Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19
• Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia
• The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation
• The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia
• Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
• Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
• A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia
• Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019
• Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
• Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19
• Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora
• Protective Effect of Aspirin on COVID-19 Patients
• A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia
• Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit
• Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
• Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial
• Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia
• Baricitinib Therapy in COVID-19
• Rhu-pGSN for Severe Covid-19 Pneumonia
• Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease
• Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia
• COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1
• Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia
• Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)
• Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia
• Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19
• Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections
• EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA
• A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19
• Efficacy of Early Administration of Tocilizumab in COVID-19 Patients
• Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19
• Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
• A Study of Auxora in Patients With Severe COVID-19 Pneumonia
• Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
• Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
• Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort
• Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort
• Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia
• Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
• Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19
• A Study of LY3127804 in Participants With COVID-19
• Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
• Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Patients
• Checkpoint Blockade in COVID-19 Pandemic
• Defibrotide in COVID-19 Pneumonia
• Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia
• TOFAcitinib in SARS-CoV2 Pneumonia
• Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis
• Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia
• Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia
• ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease
• The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia
• Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
• Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2
• Colchicine Counteracting Inflammation in COVID-19 Pneumonia
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
• A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia
• Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia
• Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
• Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis
• Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
• Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT
• Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia
• Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
• Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection
• The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
• A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
• Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia
• Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
• Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia
• Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia
• Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)
• Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19
• The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia
• Efficacy and Safety of Corticosteroids in COVID-19
• Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients
• Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
• The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia
• Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
• The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia
• A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
• Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus
• Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
• A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia
• A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia
• Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19
• Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
• Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
• Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)
• Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients
• Nebulized Colistin for Gram Negative VAP Prevention.
• ARrest RESpiraTory Failure From PNEUMONIA
• Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.
• A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (pPCV) in Adults
• Antibiotic Therapy In Respiratory Tract Infections
• Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
• Ultrasound Assessment of Metoclopramide Effect on Gastric Volume in Cesarean Section
• Treatment of ARDS With Instilled T3
• Vancomycin Dosage Strategy Based on a Trough Concentration Model
• Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.
• A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia
• Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia
• Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis
• Sphingosine-1-phosphate and Pneumonia
• Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP
• Avoiding Neuromuscular Blockers to Reduce Complications
• The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae
• Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB Pneumonia
• Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia
• Treatment and Vaccine Development of Mycoplasma Pneumoniae
• Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery
• Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex
• Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae
• Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate
• Second-generation Sequencing Guides the Treatment of Severe Pneumonia
• Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia
• Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS
• Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia
• Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
• Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia
• Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
• Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
• Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis
• ZAVI APD ELF Protocol v2.2
• Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia
• Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)
• Pulmonary Inflammation Using FNOS PET in E-cigarette
• Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer
• The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
• Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
• Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease
• Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response
• Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
• Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas
• Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumonia
• An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus Tavanic® in Adult Patients With Community-acquired Pneumo
• Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)
• Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults
• Treatment of Macrolide-resistant Mycoplasma Pneumoniae
• GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial
• PET Imaging CCR2 in Lung Inflammation
• 7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia
• Pharmacokinetics of XueBiJing in Patients With Sepsis
• KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP
• Prolonged-Use of Inhaled Gaseous Nitric Oxide (gNO) for Adult With Non-Tuberculous Mycobacteria Infection
• Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
• A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP
• The Norwegian Antibiotics for Pneumonia in Children Study
• Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0%
• Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia
• Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa
• Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Adults
• Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
• RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia
• Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
• A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
• A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
• Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
• Basiliximab Treating Interstitial Pneumonia of CADM
• Cx611-0204 SEPCELL Study
• Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
• Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis
• The Applicability of Different Scoring Systems and Use of Steroids in the Treatment of Hospital Acquired Pneumonia
• Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria
• Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
• Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.
• Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia
• Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance
• A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
• Innovative Treatments in Pneumonia (ITIP) 3
• Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis
• Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.
• Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia
• Smoking Cessation Intervention in Respiratory Inpatients
• Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia
• Nebulized and Intravenous Colistin in Ventilator Associated-pneumonia
• Phase II Study of Oral Nafithromycin in CABP
• Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children
• Community Case Management of Chest Indrawing Pneumonia
• Lung Concentrations of Ceftazidime in Patients With Ventilator-associated Pneumonia
• Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
• Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients
• Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
• Hospitalised Pneumonia With Extended Treatment (HOPE) Study
• Population Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired Pneumonia
• 3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
• Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia
• A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271
• Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
• Atropine for Preventing Ventilator-Associated Pneumonia
• Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects
• Effect of Aerosolised Colistin in Ventilator Associated Pneumonia
• Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
• 3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi
• Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia
• Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever)
• Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)
• Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia
• The Pharmacodynamics of Meropenem in Patient With Ventilator-associated Pneumonia
• Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
• Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin
• Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients
• Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia
• Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients
• Validation of Aspiration Markers in Intubated Patients
• Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease
• Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae
• Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria
• Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia
• Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
• Corticosteroid Therapy for Severe Community-Acquired Pneumonia
• Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
• Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)
• Small Airway Involvement in Patients With Chronic Hypersensitivity Pneumonitis
• Community-Acquired Pneumonia : Evaluation of Corticosteroids
• Physiotherapy in Patients Hospitalized Due to Pneumonia.
• A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia
• Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis
• Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment
• Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
• Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia
• Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
• A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia
• Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy
• Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia
• Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children
• Intra-operative Inspiratory Oxygen Fraction and Postoperative Respiratory Complications
• Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
• Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)
• Short-course Antimicrobial Therapy for Paediatric Respiratory Infections
• Randomized Trial of Amoxicillin Versus Placebo for (Fast Breathing) Pneumonia
• Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
• Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia
• Drug to Prevent Pneumonia in the Tube Fed
• Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia
• Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers
• Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)
• Validation of Aspiration Markers
• Study of the Efficacy and Safety of MEDI4893
• Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury
• A P3 Comparator Trial in Community Acquired Bacterial Pneumonia
• PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone
• Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia
• Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults
• Rituximab in Interstitial Pneumonitis
• The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia
• Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization
• A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
• Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious Complications
• Interest of Ascorbic Acid in the Management of Pneumonia in Elderly People Hospitalized.
• Vitamin-D Supplementation: Impact on Severe Pneumonia Among Under-five Children
• Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
• A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
• PTH - Preemptive Treatment for Herpesviridae
• Assessing NOS Uptake With PET Imaging in Lung Inflammation
• Pneumocystis Jerovici Pneumonia in Infants and Steroids
• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
• Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria
• Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
• Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)
• Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)
• Effectiveness Study of Integrative Treatment for Pediatric Pneumonia
• The Effect of Nebulization of Alkaline Solution on Treating XDRAB Pneumonia With C/S Plus Minocycline
• Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
• The INFECIR-2 Albumin Prevention Study
• Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
• Pharmacokinetics of Levofloxacin in Intensive Care Unit
• Ticagrelor in Severe Community Acquired Pneumonia
• Duration of Antibiotic Treatment for Early VAP (DATE) Trial
• A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
• Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
• Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
• Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
• Short Duration Treatment of Non-severe Community Acquired Pneumonia
• Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride
• Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
• A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
• Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation
• Prehospital Ventilator-Associated Pneumonia Prevention Trial
• Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma
• A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
• Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
• Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.
• Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
• The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia
• Aerosolized and Intravenous Colistin in Healthy Adults
• Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia
• Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia
• A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia
• Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia
• Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
• Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections
• Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia
• Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -
• Lactobacillus Preparation on the Incidence of Diarrhea
• Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial
• WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects
• A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
• Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
• Mitigation of Radiation Pneumonitis and Fibrosis
• Phase 1 Study Assessing the Safety and Tolerability of CTX-4430
• Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients
• Santeon-CAP; Dexamethasone in Community-acquired Pneumonia
• Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
• Validation of a Lung Inflammation Model in Healthy Volunteers by Radiological Tools and Glucocorticoid Treatment
• Short-course Antimicrobial Therapy for Paediatric Respiratory Infections
• Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)
• Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)
• Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.
• Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia
• Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients
• Catheter Outcomes With Sternotomy Cardiac Operated
• Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus
• Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit
• Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
• Corticosteroids in Community-acquired Pneumonia
• Rapamune Improves Outcomes of Severe H1N1 Pneumonia
• Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia
• Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
• Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia
• Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli
• Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)
• NSAIDs Treatment in Children With Pleuropneumonia
• Colistin and Rifampicin for MDR-Acinetobacter
• Clinical Trials to Reduce the Risk of Antimicrobial Resistance
• A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
• Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin
• Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment
• Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
• Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
• Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
• Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
• Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP
• Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
• Effect of Curcumin on Lung Inflammation
• Respiratory Syncytial Virus - RSV Protocol
• The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia
• The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
• Prevention of Post-operative Pneumonia (POPP)
• Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
• Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP
• PET Imaging of Endotoxin-induced iNOS Activation
• Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia
• Oral Versus Intravenous Dexamethasone
• Chlorhexidine Gluconate Oral Care for Adults Experiencing Trauma
• Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia
• Efficacy Study for Standard Versus Double Dose of Amoxicillin in WHO Defined Non-severe Pneumonia
• A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
• Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients
• Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
• Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo
• Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)
• Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e)
• A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
• The Optimization of Mycoplasm Pneumonia Antibiotic Therapy
• Antibiotic Efficacy in Pneumonitis Following Paraffin (Kerosene) Ingestion in Children
• Rapid Empiric Treatment With Oseltamivir Study (RETOS)
• Corticosteroids in Community Acquired Pneumonea
• Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children
• Clinical Efficacy of Amoxicillin Given Twice or Three Times a Day Among Children With Non-severe Pneumonia
• Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
• Community Case Management of the Severe Pneumonia With Oral Amoxicillin in Children 2-59 Months of Age
• The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
• Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
• Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
• Comparison Between Amoxycillin/Clavulanic Acid and Oxacillin/Ceftriaxone for Community Acquired-pneumonia
• Prophylactic Efficacy of Relenza Against Influenza A and B
• Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients
• A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
• Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine
• Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury
• The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines
• Oral Care Interventions and Ventilator Associated Pneumonia in Critically Ill Children
• Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia
• Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
• STATIN-VAP STATIN-VAP - STATINs and Ventilator-Associated Pneumonia
• BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia
• Cost Effectiveness Of Linezolid In Central America
• Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia
• Tracheobronchitis Prevention Trial
• Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
• Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu
• A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)
• CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients
• PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region
• Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial
• A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
• Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic
• Study of Povidone Iodine to Reduce Pulmonary Infection in Head Trauma and Cerebral Hemorrhage in Intensive Care Unit
• Impact of Statins on Cytokine Expression in Pneumonia
• Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS)
• Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study
• Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
• Cotrimoxazole Versus Amoxicillin in the Treatment of Community Acquired Pneumonia in Children Aged 2-59 Months
• Nebulized Colistin for Hospital-Acquired Pneumonia
• Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence
• Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
• Corticoids in Severe Community-Acquired Pneumonia (CAP)
• Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
• Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients
• Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation
• Trial of Amoxicillin Compared With Placebo for Pneumonia in Children Aged 2-59 Months
• Chlorhexidine & Pneumonia in Nursing Home Residents
• Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia
• Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage
• The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)
• NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients
• Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
• Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in Childhood
• A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization
• Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From a Stroke
• Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
• Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
• A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function
• Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae
• Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors
• Quantifying Airway Inflammation With Radiologic Tests
• Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia
• Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs
• A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia
• Oseltamivir Randomised Controlled Efficacy Trial
• Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia
• A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia
• Pravastatin and Ventilatory Associated Pneumonia
• Multicenter Infection Surveillance Study Following Open Heart Surgery
• Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia
• Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
• An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia
• Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii
• A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients
• A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients
• Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
• Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
• Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)
• Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD
• The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia
• Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
• Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment
• Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia
• Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients
• Role of Oral Chlorhexidine Gel in Prevention of Ventilator Associated Pneumonia
• To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia
• Rituximab in Rheumatoid Arthritis Lung Disease
• Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus
• Kabul Vitamin D Supplementation Trial
• Ketek in CAP / AECB in Ambulatory Adult Patients
• Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
• Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
• Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
• Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas
• A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
• Zambia Integrated Management of Malaria and Pneumonia Study
• Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia
• Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
• An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
• Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
• First Time in Man Trial for Friulimicin B
• Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
• Dexamethasone Infusion in Community-acquired Pneumonia
• Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients
• Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)
• A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)
• Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection
• Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion
• Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia
• Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia
• Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
• Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
• Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)
• Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia
• Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze
• To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)
• Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation
• ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia
• Prevention of Pneumonia Comparing Ceftriaxone With Subglottic Aspiration
• The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children
• Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children
• Elucidation of Acid-Induced Pulmonary Inflammation
• A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
• Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia
• Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
• Therapeutic Zinc in Infant Bacterial Illness
• Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
• Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)
• Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia
• Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
• DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
• Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
• Intravenous Clarithromycin in Septic Syndrome
• Effect of Zinc and Vitamin A Supplementation on Diarrhea, Physical Growth and Immune Response in Malnourished Children
• Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
• Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months
• A Study of the Safety and Effectiveness of Levofloxacin Compared With Ceftriaxone Sodium or Cefuroxime Axetil in the Treatment of Adults With Pneumonia
• The Effect of Prophylactic Probiotic Lactobacilli in Enteral Feeding on Nosocomial Pneumonia Rates in Critically Ill Patients
• Efficacy of Bifidus DR10 and Oligo Saccharides / Micronutrient Fortification of Milk
• Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia
• Therapeutic Zinc in Childhood Pneumonia
• Outpatient Registry Trial of Respiratory Tract Infections in Adults
• Outcomes of Patients Not Responding to Antibiotics in the Community
• Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days
• A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization
• A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia
• Ceftobiprole in Hospital Acquired Pneumonia
• Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study
• Equivalency Of Oral Amoxicillin Vs Injectable Penicillin In Children With Severe Pneumonia
• Doripenem in the Treatment of Ventilator-Associated Pneumonia
• Doripenem in the Treatment of Hospital-Acquired Pneumonia
• Ceftobiprole in Hospital Acquired Pneumonia
• Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting
• Mentored Patient-Oriented Research Career Development Award
• Efficacy of Zinc in the Treatment of Pneumonia
• Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
• Efficacy Studies of Corticosteroid Therapy in Community-Acquired Pneumonia
• Prophylactic Antibiotics in Measles
• Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
• The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study
• CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia
• Zinc Pneumonia Outpatient Trial in Children < 2 Years
• Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
• Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance
• Zithromax EV in Community-Acquired Pneumonia (CAP)
• Zinc and Pneumonia Protocol
• KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
• Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
• Efficacy of Single Versus Double Dose of Oral Amoxicillin for Non-Severe Pneumonia in Children
• Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
• Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients
• Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia
• A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
• Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
• Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia
• Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia
• Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
• Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
• Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
• Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia
• Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)
• Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support
• Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis
• A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis
• Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia
• New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
• A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting
• Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients
• Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
• Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
• Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
• Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
• Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
• Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
• A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)
• A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX
• A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia
• A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
• The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before
• A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
• A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)
• Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia
• A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia
• A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.
• A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS
• A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP
• A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients
• A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP
• Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)
• An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients
• A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome
• A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole
• A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
• An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine
• Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
• Interferon Gamma for Drug Resistant Tuberculosis
• A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides
• A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole
• A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies
• Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
• Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
• A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia
• A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP
• A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients
• A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia
• A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients
• Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
• A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
• Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children
• A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
• The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS
• Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects
• Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
• Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients
• A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)
• A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia
• Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy
• The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS
• A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS
• An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies
• Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms
• A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
• A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
• Penicillin Prophylaxis in Sickle Cell Disease (PROPS)